Search This Blog

Thursday, November 7, 2019

Amphastar Pharmaceuticals EPS beats by $0.03, beats on revenue

Amphastar Pharmaceuticals (NASDAQ:AMPH): Q3 Non-GAAP EPS of $0.10 beats by $0.03; GAAP EPS of $0.03.
Revenue of $80.14M (+6.1% Y/Y) beats by $1.61M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)